Asarfi Hospital

3 weeks ago

Asarfi Hospital (ASARFI): Company Update

Company Update We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating to Rs.26,93,60,000/-issued by the company for the object stated in the offer document. We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating to Rs.26,93,60,0

Continue Reading

3 weeks ago

Asarfi Hospital (ASARFI): Company Update

Company Update We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating to Rs.26,93,60,000/-issued by the company for the object stated in the offer document. We wish you to inform you for the year ended March 31, 2026, There was no material deviation in the use of proceeds of issue of 5180000 Equity Share of face value of Rs.10 each, aggregating to Rs.26,93,60,0

Continue Reading

3 weeks ago

Asarfi Hospital (ASARFI): Company Update

Company Update We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31, 2026. We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31, 2026.

Continue Reading

3 weeks ago

Asarfi Hospital (ASARFI): Company Update

Company Update We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31, 2026. We hereby submit the transcript of the earning conference call held on May 27, 2026, wherein the Audited standalone and consolidated Financial Results of the company for the Qtr4 & Year ended March 31, 2026.

Continue Reading